Press Release Biocartis Group NV: Disclosure of Transparency Notification (Article 14, First Paragraph, of the Act of 2 May 2007 on the Disclosure of Large Shareholdings)
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 M
Press Release Biocartis Group NV: Announcement Regarding Enforcement by Secured Creditors
PRESS RELEASE REGULATED INFORMATION 31 October 2023, 15:30 CET ANNOUNCEMENT REGARDING ENFORCEMENT BY SECURED CREDITORS The Company's Secured Creditors have enforced their security over the shares of t
Press Release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO)
PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla Presented at European Society of Molecular Oncology Congress (ESMO) Mechelen, Belgium, 20 October 2023 – Bioc
Press Release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month With Launch of Breast Cancer Portfolio
PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis Group NV (the 'Company' or
Press Release Biocartis Group NV: Biocartis Announces Expansion of Its Collaboration With APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit
PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Mechelen, Belgium, 12 October 2023
Press Release Biocartis Group NV: Biocartis 2023 Half-year Results Webcast on 26 September 2023
PRESS RELEASE REGULATED INFORMATION 21 September 2023, 07:00 CEST BIOCARTI
Press Release Biocartis Group NV: Biocartis Appoints New Medical Advisory Board (MAB) of Renowned Practice Leaders
PRESS RELEASE: 28 August 2023, 7:00 AM CEST Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders Mechelen, Belgium, 28 August 2023 - Biocartis Group NV (the 'Company' or 'B
Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023
PRESS RELEASE: 24 August 2023, 07:00 CEST BIOCARTIS ANNOUNCES 2023 HALF-YEAR RESULTS ON 26 SEPTEMBER 2023 Mechelen, Belgium, 24 August 2023 – Biocartis Group NV (the 'Company' or 'Biocartis'), an inno
Press Release Biocartis Group NV: Biocartis Partners With Lilly to Explore Biomarker Testing for NSCLC Patients Using the Idylla Platform
PRESS RELEASE: 10 August 2023, 07:00 CEST Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla PlatformMechelen, Belgium, 2023 - Biocartis Group NV (the 'Comp
Press Release Biocartis Group NV: Biocartis Appoints George Cardoza as New CFO and Head of Service Delivery
PRESS RELEASE - INSIDE INFORMATION/ REGULATED INFORMATION18 July 2023, 7:00 AM CEST Biocartis appoints George Cardoza as new CFO and Head of Service Delivery George Cardoza appointed as Biocartis' new
Press Release Biocartis Group NV: Biocartis Announces Planned Operational Reorganization and Cost Reduction Program
PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 15 June 2023, 17:15 CEST BIOCARTIS ANNOUNCES PLANNED OPERATIONAL REORGANIZATION AND COST REDUCTION PROGRAM Focusing inv
Press Release Biocartis Group NV: Biocartis Announces Resignation CFO
PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 5 June 2023, 17:40 CEST BIOCARTIS ANNOUNCES RESIGNATION CFO Mechelen, Belgium, 5 June 2023 – Biocartis Group NV (the 'Company' or 'Biocar
Press Release Biocartis Group NV: Results of the Annual Shareholders' Meeting Held on 12 May 2023
Press Release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023
PRESS RELEASE: REGULATED INFORMATION20 April 2023, 07:00 CEST Biocartis Reports Results of First Quarter of 2023:16% Growth of Oncology Cartridge RevenuesGross Margin on Products of 37% and EBITDA of
Press Release Biocartis Group NV: Biocartis Appoints Roger Moody as New CEO
PRESS RELEASE: INSIDE INFORMATION/ REGULATED INFORMATION11 April 2023, 22:00 CEST Biocartis appoints Roger Moody as new CEO Roger Moody to be appointed as new Chief Executive Officer and member of the
Press Release Biocartis Group NV: Invitation to the Annual Shareholders' Meeting
PRESS RELEASE: REGULATED INFORMATION 11 April 2023, 07:01 CEST Invitation to the Annual Shareholders' Meeting Mechelen, Belgium, 11 April 2023 – Biocartis Group NV (the 'Company' or 'Biocartis'), an i
Press Release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform
PRESS RELEASE: 4 April 2023, 07:00 CEST Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla platform Mechelen, Belgium, 4
Press Release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023
PRESS RELEASE - REGULATED INFORMATION 29 March 2023, 07:00 CEST Biocartis To Publish 2022 Annual Report on 11 April 2023 Mechelen, Belgium, 29 March 2023 – Biocartis Group NV (the 'Company' or 'Biocar
Press Release Biocartis Group NV: Disclosure of Transparency Notification
Press Release Biocartis Group NV: Biocartis Creates New Share Option Plan and Cancels Outstanding Pool Under Existing Share Option Plans
PRESS RELEASE - REGULATED INFORMATION 24 February 2023, 07:00 CET Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option Plans Mechelen, Belgium, 24 February
No Data